Literature DB >> 18498959

Erectile dysfunction predicts coronary heart disease in type 2 diabetes.

Ronald Ching-Wan Ma1, Wing-Yee So, Xilin Yang, Linda Wai-Ling Yu, Alice Pik-Shan Kong, Gary Tin-Choi Ko, Chun-Chung Chow, Clive Stewart Cockram, Juliana Chung-Ngor Chan, Peter Chun-Yip Tong.   

Abstract

OBJECTIVES: We examined the predictive power of erectile dysfunction (ED) on coronary heart disease (CHD) events in Chinese men with type 2 diabetes.
BACKGROUND: Subjects with diabetes are prone to develop cardiovascular complications. Erectile dysfunction is strongly associated with CHD in cross-sectional studies, but prospective data are lacking.
METHODS: A consecutive cohort of men with no clinical evidence of cardiovascular disease underwent comprehensive assessments for diabetic complications. Erectile dysfunction was defined according to the definition of the National Institutes of Health Consensus Conference 1992. Coronary heart disease events were censored with centralized territory-wide hospital databases in 2005.
RESULTS: Of 2,306 subjects (age: 54.2 +/- 12.7 years; follow-up: 4.0 [range 1.7 to 7.1] years), 26.7% had ED at baseline. The incidence of CHD events was higher in men with ED than those without (19.7/1,000 person-years, 95% confidence interval [CI] 14.3 to 25.2 person-years vs. 9.5/1,000 person-years, 95% CI 7.4 to 11.7 person-years). Men who developed CHD events were older; had a higher frequency of ED and microvascular complications; had longer duration of diabetes; and had higher blood pressure, total cholesterol, low-density lipoprotein cholesterol, and urinary albumin/creatinine ratio but lower high-density lipoprotein cholesterol and estimated glomerular filtration rate than those without CHD events. Erectile dysfunction remained an independent predictor for CHD events (hazard ratio 1.58, 95% CI 1.08 to 2.30, p = 0.018) after adjustment for other covariates along with age, duration of disease, and use of antihypertensive agents and albuminuria.
CONCLUSIONS: In type 2 diabetic men without clinically overt cardiovascular disease, the presence of ED predicts a new onset of CHD events. Symptoms of ED should be independently sought to identify high-risk subjects for comprehensive cardiovascular assessments.

Entities:  

Mesh:

Year:  2008        PMID: 18498959     DOI: 10.1016/j.jacc.2008.02.051

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  36 in total

Review 1.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

2.  Erectile dysfunction and the "window of curability": a harbinger of cardiovascular events.

Authors:  Martin M Miner
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

3.  Clinical significance and expression of microRNA in diabetic patients with erectile dysfunction.

Authors:  X I Jiang; Yong Luo; Shuli Zhao; Qichao Chen; Chao Jiang; Yutian Dai; Yun Chen; Zhigang Cao
Journal:  Exp Ther Med       Date:  2015-04-22       Impact factor: 2.447

Review 4.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

Review 5.  Management of erectile dysfunction in diabetes: an update for 2008.

Authors:  David Price; Geoffrey Hackett
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

6.  Erectile dysfunction as a coronary artery disease risk equivalent.

Authors:  John H Lee; Raphael Ngengwe; Philip Jones; Fengming Tang; James H O'Keefe
Journal:  J Nucl Cardiol       Date:  2008-09-12       Impact factor: 5.952

Review 7.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

8.  Predicting erectile dysfunction in sexually active patients seeking prostate health screening: proposal for a multivariable risk stratification.

Authors:  V Favilla; G I Russo; G Reale; S Leone; T Castelli; S La Vignera; R A Condorelli; A E Calogero; S Cimino; G Morgia
Journal:  Int J Impot Res       Date:  2015-07-30       Impact factor: 2.896

9.  The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.

Authors:  G Corona; C B Giorda; D Cucinotta; P Guida; E Nada
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.